Skip to content

Study on prediction of curative effect of depression

A longitudinal study of efficacy prediction of antidepressants on depression based on neurocognitive and optimized multimodal neuroimaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058518
Enrollment
Unknown
Registered
2022-04-10
Start date
2022-04-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Depression group:Antidepressants (fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, esitalopram, venlafaxine)
Healthy control group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for patients with depression: (1) Meet the diagnostic criteria for major depressive disorder in DSM-?; (2) Demographic information criteria: aged 18-60 years, Han nationality, right-handed; (3) First episode without prior use of any antidepressants, antipsychotics, or sedative sleeping pills; (4) Clinical treatment is consistent with the sequential treatment plan of this study. 2. Inclusion criteria of healthy volunteers: (1) Demographic information criteria: aged 18-60 years, Han nationality, right-handed; (2) Intelligence level: intelligence of Wechsler >= 90, education level: graduation from primary school or education age >= 6 years; (3) Complete social function (normal work, school, not illness), with full behavior and responsibility ability.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for patients with depression: (1) Patients with serious physical or neurological diseases; (2) Patients with metal objects (such as metal dentures, cardiac pacemakers, etc.) in the body affecting the MRI examination; (3) Patients with color blindness, etc. can not effectively complete the examination. 2. Exclusion criteria for healthy subjects: (1) Disease history: subjects diagnosed with DSM-? axis ? and axis ?, with serious organic diseases of body and brain; (2) Drug treatment history: used to take psychotropic drugs; (3) Family history: a family history of mental illness in two or three generations; (4) Subjects with metal objects (such as metal dentures, cardiac pacemakers, etc.) in the body affecting the MRI examination; (5) Colorblind subjects who cannot effectively complete the assessment.

Design outcomes

Primary

MeasureTime frame
Cranial MRI;Hamilton Depression Questionnaire -17;Beck Depression Inventory-21;Environmental Factors Assessment Scale;Cognitive symptoms;

Secondary

MeasureTime frame
Young's Mania Rating Scale;Hamilton Anxiety Scale;Beck Depression Inventory;Childhood Trauma Questionnaire -28;Ottawa Self-injury Scale;Temporal Experience of Pleasure Scale;Pittsburgh Sleep Quality Index Scale;Morningness-Eveningness Questionaire;Epworth Sleepiness Scale;Social Support Rating Scale;Eysenck Personality Questionnaire;Life Event Scale;

Countries

China

Contacts

Public ContactYang Xiao

West China Hospital of Sichuan University

yangxiao@wchscu.cn+86 13881917332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026